Celularity Inc. (NASDAQ: CELU)
$2.7050
-0.1450 ( -4.75% ) 43.7K
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.
Market Data
Open
$2.7050
Previous close
$2.8500
Volume
43.7K
Market cap
$57.21M
Day range
$2.6110 - $2.8800
52 week range
$1.3000 - $7.9700
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
3 | Insider transactions | 2 | Aug 28, 2024 |
8-k | 8K-related | 15 | Aug 28, 2024 |
4 | Insider transactions | 1 | Aug 28, 2024 |
8-k | 8K-related | 14 | Aug 23, 2024 |
nt | Quarterly Reports | 1 | Aug 16, 2024 |
8-k | 8K-related | 15 | Aug 05, 2024 |
10-k | Annual reports | 119 | Jul 30, 2024 |
8-k | 8K-related | 14 | May 24, 2024 |
8-k | 8K-related | 74 | May 21, 2024 |
nt | Quarterly Reports | 1 | May 15, 2024 |